Royal Bank of Canada’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Royal Bank of Canada’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.6M	Sell	12,500 -9,600	-43%	-$1.2M	﹤0.01%	3264
2025 Q4	$2.69M	Hold	22,100	–	–	﹤0.01%	2910
2025 Q3	$2.21M	Buy	22,100 +5,000	+29%	+$450K	﹤0.01%	3325
2025 Q2	$1.42M	Hold	17,100	–	–	﹤0.01%	3600
2025 Q1	$1.39M	Sell	17,100 -100,000	-85%	-$8.94M	﹤0.01%	3224
2024 Q4	$10.5M	Hold	117,100	–	–	﹤0.01%	1760
2024 Q3	$11.6M	Sell	117,100 -187,500	-62%	-$18.4M	﹤0.01%	1682
2024 Q2	$28.2M	Buy	304,600 +125,000	+70%	+$11.2M	0.01%	1063
2024 Q1	$17M	Sell	179,600 -13,000	-7%	-$1.21M	﹤0.01%	1353
2023 Q4	$17.2M	Buy	192,600 +4,600	+2%	+$342K	﹤0.01%	1370
2023 Q3	$13.7M	Buy	188,000 +113,000	+151%	+$9.03M	﹤0.01%	1367
2023 Q2	$6.24M	Buy	+75,000	New	+$6.27M	﹤0.01%	1932
2021 Q1	–	Sell	-200	Closed	-$28K	–	7740
2020 Q4	$28K	Hold	200	–	–	﹤0.01%	5911
2020 Q3	$22K	Hold	200	–	–	﹤0.01%	5667
2020 Q2	$22K	Sell	200 -200,000	-100%	-$19.7M	﹤0.01%	5557
2020 Q1	$15.5M	Buy	200,200 +200,000	+100,000%	+$17.7M	0.01%	1051
2019 Q4	$19K	Buy	+200	New	+$17.3K	﹤0.01%	5879
2019 Q2	–	Sell	-600	Closed	-$54K	–	7236
2019 Q1	$54K	Buy	+600	New	+$51K	﹤0.01%	5120
2017 Q1	–	Sell	-104,500	Closed	-$6.18M	–	6850
2016 Q4	$6.18M	Sell	104,500 -40,000	-28%	-$2.47M	﹤0.01%	1811
2016 Q3	$9.58M	Buy	+144,500	New	+$8.94M	0.01%	1509

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Royal Bank of Canada's XBI Position: Q1 2026 in Review

Royal Bank of Canada increased its State Street SPDR S&P Biotech ETF (XBI) stake by 3.8% in Q1 2026, buying an estimated $2.3M and bringing the position to 510,065 shares worth $65.2M. The position accounts for 0.01% of the portfolio, ranked #800.

Royal Bank of Canada first reported a position in XBI in Q2 2013 and has held it in 52 quarters since. The position peaked at $102M in Q1 2024. 815 funds tracked by Wall St. Rank hold XBI as of Q1 2026.

Royal Bank of Canada held 510,065 shares of State Street SPDR S&P Biotech ETF worth $65.2M as of Q1 2026.
Royal Bank of Canada bought 18,452 State Street SPDR S&P Biotech ETF shares in Q1 2026, an estimated $2.3M.
State Street SPDR S&P Biotech ETF made up 0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #800 holding.
Royal Bank of Canada first reported a position in State Street SPDR S&P Biotech ETF in Q2 2013 and has held it in 52 quarters since.
Royal Bank of Canada's State Street SPDR S&P Biotech ETF position peaked at $102M in Q1 2024.
815 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.